A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss

Anne W. Lucky(Fu Associates (United States)), Daniel Piacquadio(La Jolla Alcohol Research), Chérie M. Ditre(Hahnemann University Hospital), Frank Dunlap(Radiant Research (United States)), Irwin Kantor(Icahn School of Medicine at Mount Sinai), Amit G. Pandya(The University of Texas Southwestern Medical Center), R Savin, Michael D. Tharp(Presbyterian St. Luke's Medical Center)

Journal of the American Academy of Dermatology

March 20, 2004

10.1016/j.jaad.2003.06.014

Cited by 297

Abstract

Related Papers

Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex

E. Ludwig|British Journal of Dermatology|1977|871

Treatment of Hair Loss

Vera H. Price|New England Journal of Medicine|1999|432

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men

Elise A. Olsen, Frank Dunlap, Toni Funicella et al.|Journal of the American Academy of Dermatology|2002|418

Female pattern hair loss

Elise A. Olsen|Journal of the American Academy of Dermatology|2001|298

Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment

V. H. Price, Emory Menefee, Paul C. Strauss|Journal of the American Academy of Dermatology|1999|157